vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and WATTS WATER TECHNOLOGIES INC (WTS). Click either name above to swap in a different company.
WATTS WATER TECHNOLOGIES INC is the larger business by last-quarter revenue ($625.1M vs $493.8M, roughly 1.3× Pediatrix Medical Group, Inc.). WATTS WATER TECHNOLOGIES INC runs the higher net margin — 13.4% vs 6.8%, a 6.6% gap on every dollar of revenue. On growth, WATTS WATER TECHNOLOGIES INC posted the faster year-over-year revenue change (15.7% vs -1.7%). Over the past eight quarters, WATTS WATER TECHNOLOGIES INC's revenue compounded faster (4.6% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
AERCO International, Inc. is a manufacturer and supplier of commercial condensing boilers, high efficiency water heating equipment and energy recovery systems in the HVAC/plumbing industry across a variety of markets including education, lodging, government, office buildings, healthcare, industrial and multifamily housing. In 1949, AERCO introduced the industry's first semi-instantaneous, tankless steam-to-water water heater. In 1988, AERCO introduced the first condensing and fully modulating...
MD vs WTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $625.1M |
| Net Profit | $33.7M | $83.7M |
| Gross Margin | — | 49.5% |
| Operating Margin | 9.9% | 18.2% |
| Net Margin | 6.8% | 13.4% |
| Revenue YoY | -1.7% | 15.7% |
| Net Profit YoY | 10.5% | 24.0% |
| EPS (diluted) | $0.40 | $2.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $625.1M | ||
| Q3 25 | $492.9M | $611.7M | ||
| Q2 25 | $468.8M | $643.7M | ||
| Q1 25 | $458.4M | $558.0M | ||
| Q4 24 | $502.4M | $540.4M | ||
| Q3 24 | $511.2M | $543.6M | ||
| Q2 24 | $504.3M | $597.3M | ||
| Q1 24 | $495.1M | $570.9M |
| Q4 25 | $33.7M | $83.7M | ||
| Q3 25 | $71.7M | $82.2M | ||
| Q2 25 | $39.3M | $100.9M | ||
| Q1 25 | $20.7M | $74.0M | ||
| Q4 24 | $30.5M | $67.5M | ||
| Q3 24 | $19.4M | $69.1M | ||
| Q2 24 | $-153.0M | $82.0M | ||
| Q1 24 | $4.0M | $72.6M |
| Q4 25 | — | 49.5% | ||
| Q3 25 | — | 48.8% | ||
| Q2 25 | — | 50.6% | ||
| Q1 25 | — | 48.8% | ||
| Q4 24 | — | 46.7% | ||
| Q3 24 | — | 47.3% | ||
| Q2 24 | — | 47.7% | ||
| Q1 24 | — | 46.9% |
| Q4 25 | 9.9% | 18.2% | ||
| Q3 25 | 13.8% | 18.2% | ||
| Q2 25 | 12.8% | 21.0% | ||
| Q1 25 | 7.0% | 15.7% | ||
| Q4 24 | 7.8% | 16.5% | ||
| Q3 24 | 6.6% | 17.1% | ||
| Q2 24 | -31.3% | 18.7% | ||
| Q1 24 | 3.2% | 16.9% |
| Q4 25 | 6.8% | 13.4% | ||
| Q3 25 | 14.5% | 13.4% | ||
| Q2 25 | 8.4% | 15.7% | ||
| Q1 25 | 4.5% | 13.3% | ||
| Q4 24 | 6.1% | 12.5% | ||
| Q3 24 | 3.8% | 12.7% | ||
| Q2 24 | -30.3% | 13.7% | ||
| Q1 24 | 0.8% | 12.7% |
| Q4 25 | $0.40 | $2.50 | ||
| Q3 25 | $0.84 | $2.45 | ||
| Q2 25 | $0.46 | $3.01 | ||
| Q1 25 | $0.24 | $2.21 | ||
| Q4 24 | $0.37 | $2.02 | ||
| Q3 24 | $0.23 | $2.06 | ||
| Q2 24 | $-1.84 | $2.44 | ||
| Q1 24 | $0.05 | $2.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $405.5M |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $2.0B |
| Total Assets | $2.2B | $2.9B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $405.5M | ||
| Q3 25 | $340.1M | $457.7M | ||
| Q2 25 | $224.7M | $369.3M | ||
| Q1 25 | $99.0M | $336.8M | ||
| Q4 24 | $229.9M | $386.9M | ||
| Q3 24 | $103.8M | $303.9M | ||
| Q2 24 | $19.4M | $279.4M | ||
| Q1 24 | $8.0M | $237.1M |
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $2.0B | ||
| Q3 25 | $890.7M | $2.0B | ||
| Q2 25 | $833.8M | $1.9B | ||
| Q1 25 | $789.2M | $1.8B | ||
| Q4 24 | $764.9M | $1.7B | ||
| Q3 24 | $732.5M | $1.7B | ||
| Q2 24 | $706.5M | $1.6B | ||
| Q1 24 | $856.2M | $1.6B |
| Q4 25 | $2.2B | $2.9B | ||
| Q3 25 | $2.2B | $2.7B | ||
| Q2 25 | $2.1B | $2.6B | ||
| Q1 25 | $2.0B | $2.5B | ||
| Q4 24 | $2.2B | $2.4B | ||
| Q3 24 | $2.1B | $2.4B | ||
| Q2 24 | $2.0B | $2.4B | ||
| Q1 24 | $2.2B | $2.3B |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $154.7M |
| Free Cash FlowOCF − Capex | — | $140.3M |
| FCF MarginFCF / Revenue | — | 22.4% |
| Capex IntensityCapex / Revenue | — | 2.3% |
| Cash ConversionOCF / Net Profit | 3.39× | 1.85× |
| TTM Free Cash FlowTrailing 4 quarters | — | $356.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $154.7M | ||
| Q3 25 | $137.3M | $122.4M | ||
| Q2 25 | $137.2M | $69.7M | ||
| Q1 25 | $-117.5M | $55.2M | ||
| Q4 24 | $133.0M | $139.5M | ||
| Q3 24 | $91.8M | $90.7M | ||
| Q2 24 | $107.0M | $85.3M | ||
| Q1 24 | $-125.2M | $45.6M |
| Q4 25 | — | $140.3M | ||
| Q3 25 | — | $110.9M | ||
| Q2 25 | — | $59.5M | ||
| Q1 25 | — | $45.6M | ||
| Q4 24 | — | $127.5M | ||
| Q3 24 | — | $84.3M | ||
| Q2 24 | — | $78.5M | ||
| Q1 24 | — | $35.5M |
| Q4 25 | — | 22.4% | ||
| Q3 25 | — | 18.1% | ||
| Q2 25 | — | 9.2% | ||
| Q1 25 | — | 8.2% | ||
| Q4 24 | — | 23.6% | ||
| Q3 24 | — | 15.5% | ||
| Q2 24 | — | 13.1% | ||
| Q1 24 | — | 6.2% |
| Q4 25 | — | 2.3% | ||
| Q3 25 | — | 1.9% | ||
| Q2 25 | — | 1.6% | ||
| Q1 25 | — | 1.7% | ||
| Q4 24 | — | 2.2% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 1.1% | ||
| Q1 24 | — | 1.8% |
| Q4 25 | 3.39× | 1.85× | ||
| Q3 25 | 1.91× | 1.49× | ||
| Q2 25 | 3.49× | 0.69× | ||
| Q1 25 | -5.66× | 0.75× | ||
| Q4 24 | 4.36× | 2.07× | ||
| Q3 24 | 4.72× | 1.31× | ||
| Q2 24 | — | 1.04× | ||
| Q1 24 | -31.03× | 0.63× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
WTS
Segment breakdown not available.
